We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial.
- Authors
Hansson, L; Lindholm, L H; Niskanen, L; Lanke, J; Hedner, T; Niklason, A; Luomanmäki, K; Dahlöf, B; de Faire, U; Mörlin, C; Karlberg, B E; Wester, P O; Björck, J E
- Abstract
Angiotensin-converting-enzyme (ACE) inhibitors have been used for more than a decade to treat high blood pressure, despite the lack of data from randomised intervention trials to show that such treatment affects cardiovascular morbidity and mortality. The Captopril Prevention Project (CAPPP) is a randomised intervention trial to compare the effects of ACE inhibition and conventional therapy on cardiovascular morbidity and mortality in patients with hypertension.
- Publication
Lancet (London, England), 1999, Vol 353, Issue 9153, p611
- ISSN
0140-6736
- Publication type
Journal Article
- DOI
10.1016/s0140-6736(98)05012-0